The Claude Crash: A Tale of AI Disruption and Market Panic
The FTSE 100 index, hovering near record highs, masks a dramatic story unfolding in the shadows. Dubbed the "Claude Crash" by The Guardian, this narrative revolves around the AI firm Anthropic's integration of legal products into its office assistant, Claude Cowork. But what's all the fuss about?
The recent launch has sent shockwaves through the market, particularly impacting UK's data-centric giants like Relx, London Stock Exchange Group, Experian, Sage, and Informa. These companies, once considered stable and successful, now face an AI-driven upheaval. Among them, Relx, formerly known as Reed Elsevier, stands out with its impressive portfolio, including The Lancet and LexisNexis.
Here's the twist: Relx's share price journey has been remarkable. From £5 in 2012 to a staggering £41 in May 2025, the company's value soared to approximately £70bn, securing its place as the fifth-largest in the FTSE 100 index. But the introduction of Claude's legal plug-ins has shaken things up. The share price has halved, and the market's perception of Relx has shifted from an AI winner to a potential victim of AI disruption.
But here's where it gets controversial. Despite the market's jitters, Relx's latest full-year results paint a confident picture. With revenues and operating profits up 7% and 9%, respectively, and a bold forecast of strong growth in 2026, the company is doubling down on its AI integration. CEO Erik Engström argues that AI tools, particularly workflow products for document management, are not a threat but an opportunity.
Relx's unique value lies in its proprietary information, a treasure trove of data, judgments, and interpretations accumulated over decades. This data is licensed, public, or hard to find, and it's this exclusivity that sets Relx apart. While AI may enhance its offerings, the company's core strength remains its irreplaceable data.
And this is the part most people miss: Relx's strategic response to the AI evolution is straightforward. With the share price halved, the company should continue buying back shares, as it has been doing. This year's £2.25bn buyback, a significant increase from £1.5bn, is a step in the right direction. Such a move not only boosts earnings per share but also signals confidence in the company's long-term growth, as Engström predicts.
Other companies facing similar AI-related concerns, like LSEG, are also considering larger buybacks. But is this the right strategy? Is the market overreacting to AI's potential, or are these companies genuinely at risk? Share your thoughts and let's spark a discussion on the future of AI and its impact on traditional businesses.
